BioSpace News Archive

Business

Check-Cap Reports Fourth Quarter and Full Year 2017 Financial Results

Announces the achievement of key validation milestones in C-Scan® system clinical and regulatory pathway

April 4, 2018

·

25 min read

Business

PTC Therapeutics and CHDI Foundation Announce a Collaboration on a Small-Molecule Therapeutic for Huntington’s Disease

The program is optimizing small-molecule compounds--identified using PTC’s splicing technology platform--that decrease the production of huntingtin protein.

April 4, 2018

·

5 min read

Business

Q-State Biosciences and Vertex Pharmaceuticals Enter into Multi-Year Drug Discovery Collaboration

Q-State Biosciences, Inc. today announced that the company has entered into a strategic collaboration with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to discover drugs using Q-State’s novel Optopatch™ platform.

April 4, 2018

·

2 min read

Biotech Beach

Cidara Therapeutics to Present Rezafungin Data at the European Congress of Clinical Microbiology and Infectious Diseases 2018 Meeting

Company secures four oral presentations, including three that will highlight new data demonstrating activity of rezafungin against Candida auris and azole-resistant Aspergillus

April 4, 2018

·

6 min read

Bio NC

Tenax Therapeutics Announces Results of Pre-IND Meeting with FDA for Phase 2 Study of Levosimendan in PH-HFpEF Patients

FDA addressed the Company’s questions and provided guidance on its upcoming Phase 2 clinical trial in the use of levosimendan for treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction

April 4, 2018

·

3 min read

Genetown

Siamab Therapeutics to Present New Data on its ST1 Antibody Therapeutic Program Targeting

Tumor-Associated STn and STn+ Myeloid Derived Suppressor Cells at the AACR Annual Meeting 2018

April 4, 2018

·

4 min read

FDA

U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations

FDA Priority Review Granted for U.S. New Drug Application

April 4, 2018

·

9 min read

Business

Arsanis Out-Licenses Preclinical Stage E. coli Monoclonal Antibodies

Transaction provides potential for further development of novel mAbs while allowing Arsanis to continue to focus its resources on ongoing Phase 2 clinical trial of lead product candidate ASN100

April 4, 2018

·

6 min read

Job Trends

Vivaldi Biosciences Presents Data at the World Vaccine Congress Demonstrating Potential of deltaFLU as Universal Influenza Vaccine

deltaFLU Outperformed Licensed Vaccine Against Drifted and Shifted Influenza Strains

April 4, 2018

·

7 min read

Xyntek Announces Participation in Several Upcoming Technology Shows & Conferences

Xyntek, a Global Leader in IT, Automation, & Compliance solutions have committed to participate in several upcoming industry technology shows and conferences in the upcoming months.

April 4, 2018

·

4 min read